Abstract:With the increase of global cancer morbidity and mortality, it is of great importance to control the development of cancer. In recent years, plenty of strategies have been developed for tumor diagnosis and therapy. As one of the major approaches, ligand-mediated receptor-introduced drug delivery has been extensively studied over the past decade. Our laboratory mainly engages in the related researches on the combined diagnosis and treatment of tumors, especially glioma. A series of smart biocompatible theranostic systems were designed and constructed, including precise oligomer-based nanoparticles, polymer-coated nitrogen carbon nanodots, multifunctional mesoporous silica graphite nanosheets, magnetic graphene mesoporous silica nanoparticles, etc. Then, based on the design of specific ligand-receptor targeting strategies such as IL-13, Angiopep and I6P7, these systems were applied for tumor-targeted drug delivery, gene therapy, photothermal therapy and tumor imaging. For example, the nuclear localization signal sequence LNP in Lim kinase 2 protein, was used to modify the dendrimer-based nano gene delivery system. With the ability to cross the blood-brain barrier, the translocation efficiency of nanoparticles and anti-glioma effect were improved. And, the new controlled drug delivery system, using graphene as nanocarrier, was prepared with excellent properties, such as pHand NIRresponsive, and controlled drug release, showing chemotherapeutic and photothermal synergistic therapy of glioma. A receptor-mediated cascade-targeting drug delivery system, which constructed by polymer-coated nitrogen-carbon nanodots and a multifunctional peptide (I6P7) with the ability to transport through the blood-brain barrier, target glioma and inhibit the expression of tumor growth factors, were constructed for the imaging-guided combined glioma therapy. Relating work provides new ideas and theoretical basis for cancer theragnosis.

Recent Advances on Peptide‐based Theranostic Nanomaterials

Peptide‐Based Multifunctional Nanomaterials for Tumor Imaging and Therapy

Applications of Peptide-based Nanomaterials in Targeting Cancer Therapy

Peptide-Based Nanomaterials for Tumor Immunotherapy

Supramolecular peptide nano-assemblies for cancer diagnosis and therapy: from molecular design to material synthesis and function-specific applications

Peptide-based nanoprobes for molecular imaging and disease diagnostics

Theranostic nanoparticles with disease-specific administration strategies

Peptide-based nanomaterials for gene therapy

Recent Development on Peptide-Based Probes for Multifunctional Biomedical Imaging

Peptide-Based Nanoassemblies in Gene Therapy and Diagnosis: Paving the Way for Clinical Application

Peptide‐conjugated Nanoparticle Platforms for Targeted Delivery, Imaging, and Biosensing Applications

Advanced Functional Nanomaterials for Theranostics

Advanced Peptide Nanomedicines for Bladder Cancer Theranostics

Peptide-Conjugated Nano Delivery Systems for Therapy and Diagnosis of Cancer

Activatable Peptide-Based Nanoprobes for Multimodal Imaging in Vivo

Peptide-Enabled Targeted Delivery Systems for Therapeutic Applications

Peptide-Mediated Tumor-Targeted Diagnosis and Therapy

Bio-Conjugated Advanced Materials for Targeted Disease Theranostics

Design, fabrication, and biomedical applications of bioinspired peptide–inorganic nanomaterial hybrids

Recent progress in functional peptides designed for tumor-targeted imaging and therapy

Therapeutic peptides: current applications and future directions